MARKET

CDNA

CDNA

Caredx
NASDAQ
9.90
+0.02
+0.20%
Opening 12:28 12/04 EST
OPEN
9.79
PREV CLOSE
9.88
HIGH
9.97
LOW
9.64
VOLUME
469.15K
TURNOVER
0
52 WEEK HIGH
18.04
52 WEEK LOW
4.800
MARKET CAP
535.57M
P/E (TTM)
-5.8859
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CDNA last week (1127-1201)?
Weekly Report · 1d ago
Best Growth Stocks for December 2023
Health technology and biotech companies are well represented in the top growth stocks for december 2023. Growth stocks tend to perform better when the economy is expanding and the cost of borrowing is low. Health technology companies are expected to outperform the broader market in the years to come.
Investopedia · 3d ago
Weekly Report: what happened at CDNA last week (1120-1124)?
Weekly Report · 11/27 11:11
Weekly Report: what happened at CDNA last week (1113-1117)?
Weekly Report · 11/20 11:08
Hold Rating Maintained on CareDx Amidst Management Changes and Financial Performance: An Analysis
TipRanks · 11/13 12:56
Weekly Report: what happened at CDNA last week (1106-1110)?
Weekly Report · 11/13 11:02
Caredx: Report of proposed sale of securities
Press release · 11/10 01:46
CareDx stock climbs after Q3 beats, guidance boost
Caredx shares jumped as much as 26% after the medical equipment firm reported better-than-expected third quarter results. Caredx also raised revenue outlook for 2023. Q3 revenue of $67.2m was well ahead of consensus, but fell 15% y/y.
Seeking Alpha · 11/09 17:31
More
About CDNA
CareDx, Inc. is a precision medicine company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its suite of AlloSeq products includes AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.